Dramamine Chewable Orange Tablet, Chewable
NDC 63029-915
Product Information
Dramamine Chewable Orange (meclizine hydrochloride) is a OTC MONOGRAPH DRUG-approved product labeled by Medtech Products Inc.. This medication is typically used as a antiemetic [epc]. It is supplied as a orange tablet, chewable for oral administration. This product entry covers the primary NDC 63029-915 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
D25
Code Structure Chart
Product Details
What is NDC 63029-915?
What are the uses of this product?
What are Active Ingredients of this product?
- MECLIZINE HYDROCHLORIDE 25 mg/1 - A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO)
- MECLIZINE (UNII: 3L5TQ84570) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- ASCORBIC ACID (UNII: PQ6CK8PD0R)
- BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
- STARCH, CORN (UNII: O8232NY3SJ)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- CROSPOVIDONE (UNII: 2S7830E561)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MALTODEXTRIN (UNII: 7CVR7L4A2D)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STEARIC ACID (UNII: 4ELV7Z65AP)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.